Camelot Portfolios’s Solventum SOLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,532
Closed -$121K 573
2025
Q4
$121K Buy
+1,532
New +$117K 0.07% 221
2025
Q2
Sell
-3,534
Closed -$269K 223
2025
Q1
$269K Buy
3,534
+184
+5% +$13.7K 0.17% 159
2024
Q4
$221K Sell
3,350
-1,032
-24% -$72.2K 0.24% 112
2024
Q3
$306K Sell
4,382
-2,534
-37% -$152K 0.3% 99
2024
Q2
$366K Buy
+6,916
New +$420K 0.21% 117

Other funds holding SOLV

Camelot Portfolios's SOLV Position: Q1 2026 in Review

Camelot Portfolios sold out of Solventum (SOLV) in Q1 2026, closing a stake of 1,532 shares — an estimated $121K sold.

Camelot Portfolios first reported a position in SOLV in Q2 2024 and held it in 5 quarters. The position peaked at $366K in Q2 2024. 881 funds tracked by Wall St. Rank hold SOLV as of Q1 2026.

  • Camelot Portfolios reported no remaining Solventum position as of Q1 2026 after selling out during the quarter.
  • Camelot Portfolios sold 1,532 Solventum shares in Q1 2026, an estimated $121K.
  • Camelot Portfolios first reported a position in Solventum in Q2 2024 and held it in 5 quarters.
  • Camelot Portfolios's Solventum position peaked at $366K in Q2 2024.
  • 881 funds tracked by Wall St. Rank held Solventum as of Q1 2026.

Based on Camelot Portfolios's 13F filing for Q1 2026, filed 8 May 2026.